# Uncertainty communication, trust and health promotion

**Authors:** Jeremy D. Gretton, Angela Mastroianni

PMC · DOI: 10.24095/hpcdp.45.10.04 · Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice · 2025-10-01

## TL;DR

This paper explores how health communicators can effectively share uncertainty while maintaining public trust to improve health promotion.

## Contribution

The paper introduces best practices for communicating uncertainty in health promotion to maintain trust and improve outcomes.

## Key findings

- Acknowledging uncertainty can be done without harming trust in health communicators.
- Communicators should emphasize the positive aspects of uncertainty, such as growing evidence.
- Long-term trust outcomes may differ from short-term effects of uncertainty communication.

## Abstract

Health promotion is more effective when health communicators are considered trustworthy. However, health communicators must often deal with uncertainties in the knowledge base on which they rely. In this commentary, we discuss the benefits of acknowledging uncertainty, with caveats and best practices to cultivate trust. We recommend determining the type of uncertainty involved and selecting appropriate communication approaches. We also advise that communicators emphasize the positive elements of the uncertainty, whenever possible, such as when it reflects a growing evidence base. Health promoters should consider the long-term outcomes of communicating uncertainty, as these may differ from the short-term outcomes. We identify knowledge gaps and areas ripe for future research.

We also show that uncertainty can often be communicated without harming trust in the communicator, and that communicators should rely on evidence-based best practices. We aim to provoke further discussion on how uncertainty should be understood and framed in health promotion efforts, guiding communicators on how to maintain public trust amid unknowns.

## Full-text entities

- **Diseases:** acne medication (MESH:D000152), cancer (MESH:D009369), COVID-19 (MESH:D000086382), flu (MESH:D007251), prostate cancer (MESH:D011471), long COVID (MESH:D000094024)
- **Chemicals:** lycopene (MESH:D000077276), carbohydrate (MESH:D002241), alcohol (MESH:D000438)
- **Species:** Gammacoronavirus (genus) [taxon 694013], H7N3 subtype (serotype) [taxon 119215], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12652265/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12652265/full.md

---
Source: https://tomesphere.com/paper/PMC12652265